<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00871819</url>
  </required_header>
  <id_info>
    <org_study_id>A2008</org_study_id>
    <nct_id>NCT00871819</nct_id>
  </id_info>
  <brief_title>Optimized Programming in Spinal Cord Stimulation (SCS) System</brief_title>
  <acronym>OP</acronym>
  <official_title>Optimized Programming in a Multiple-Independent Current Sources Spinal Cord Stimulation (SCS) System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate extent, location, and perception of paresthesia as&#xD;
      a function of anode/cathode configuration.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The clinical results from this study may help to validate predictions made by mathematical&#xD;
      models of neurons that are activated by SCS and increase scientific knowledge about the way&#xD;
      in which different programs relate to satisfactory outcomes, such that use of the model may&#xD;
      help in the development of new products.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation Coefficient Between Dorsal Root Paresthesia (Total Pixels Derived From Digital Drawing) at Maximum-comfortable Stimulation Level and Anode-cathode Separation Distance (mm)</measure>
    <time_frame>Immediately post-procedure</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Neuropathic Pain</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Spinal Cord Stimulation Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Spinal Cord Stimulation (SCS) Treatment Group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Precision Spinal Cord Stimulation (SCS)</intervention_name>
    <description>Various SCS device programming parameters</description>
    <arm_group_label>Spinal Cord Stimulation Group</arm_group_label>
    <other_name>Precision Spinal Cord Stimulation System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Be previously implanted with Precision SCS System (3-36 months post permanent implant)&#xD;
             having 2 parallel percutaneous leads placed between T8-T10.&#xD;
&#xD;
          -  Be implanted with Precision SCS System for the treatment of neuropathic pain of trunk&#xD;
             and/or limbs&#xD;
&#xD;
          -  Be 18 years of age or older&#xD;
&#xD;
          -  Be extremely satisfied, very satisfied, or satisfied with SCS therapy for treatment of&#xD;
             pain condition&#xD;
&#xD;
          -  Be able to use pen tablet to document regions of paresthesia and pain&#xD;
&#xD;
          -  Be able to lie in the supine position for 45 minutes at a minimum&#xD;
&#xD;
          -  Be able to verbally report qualitative and quantitative aspects of paresthesia&#xD;
             sensations.&#xD;
&#xD;
          -  Have a paresthesia threshold on a standard program below 4mA while in the supine&#xD;
             position&#xD;
&#xD;
          -  Have at minimum the upper contact of one lead below T8 and the lower contact above T11&#xD;
             vertebral levels&#xD;
&#xD;
          -  Be willing and able to comply with study-related procedure&#xD;
&#xD;
          -  Agree to study requirements and provides written Informed Consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable to read, write, speak, and understand English&#xD;
&#xD;
          -  Currently pregnant or planning to become pregnant during the course of the study&#xD;
&#xD;
          -  Have negative finding in any of the pre-screening and screening requirements&#xD;
&#xD;
          -  Upon fluoroscopy, location of both leads is identified to be outside T8-T10 vertebral&#xD;
             levels&#xD;
&#xD;
          -  Unable to perceive the sensation of paresthesia associated with stimulation in the&#xD;
             trunk and/or lower extremities&#xD;
&#xD;
          -  Have a drug pump and/or a non-Precision neurostimulation device (regardless of whether&#xD;
             active or inactive)&#xD;
&#xD;
          -  Have had any interventional pain procedure or surgeries (including Interlaminar&#xD;
             epidural steroid injection, Transforaminal epidural steroid injection, Caudal epidural&#xD;
             steroid injection, Selective nerve root block, Intraarticular lumbar facet injection,&#xD;
             Sacroiliac joint injection, Piriformis muscle injection, Trochanteric bursa injection,&#xD;
             Hip/knee joint injections, Medial branch block (innervates facet joint), Pulsed&#xD;
             radiofrequency neurotomy medial branches, Pulsed radiofrequency dorsal root ganglion,&#xD;
             Thermal (high temperature) radiofrequency neurotomy medial branches, Trigger point&#xD;
             injections, and Botulinum toxin injections) involving the spine within the past 30&#xD;
             days&#xD;
&#xD;
          -  Have any condition that is likely to confound evaluation of study endpoints.&#xD;
             Conditions that may make paresthesia coverage variable over the course of the study&#xD;
             include multiple sclerosis, partial spinal cord injury, diabetic peripheral&#xD;
             neuropathy, peripheral vascular disease, scoliosis, deafferentation, etc.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicholas Kormylo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Diego Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <study_first_submitted>March 27, 2009</study_first_submitted>
  <study_first_submitted_qc>March 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2009</study_first_posted>
  <results_first_submitted>February 13, 2012</results_first_submitted>
  <results_first_submitted_qc>March 7, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 4, 2012</results_first_posted>
  <last_update_submitted>November 5, 2013</last_update_submitted>
  <last_update_submitted_qc>November 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spinal Cord Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Spinal Cord Stimulation Group</title>
          <description>Spinal Cord Stimulation (SCS) Treatment Group</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Spinal Cord Stimulation Group</title>
          <description>Spinal Cord Stimulation (SCS) Treatment Group</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Correlation Coefficient Between Dorsal Root Paresthesia (Total Pixels Derived From Digital Drawing) at Maximum-comfortable Stimulation Level and Anode-cathode Separation Distance (mm)</title>
        <time_frame>Immediately post-procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>All enrolled subjects</description>
          </group>
        </group_list>
        <measure>
          <title>Correlation Coefficient Between Dorsal Root Paresthesia (Total Pixels Derived From Digital Drawing) at Maximum-comfortable Stimulation Level and Anode-cathode Separation Distance (mm)</title>
          <units>Correlation coefficient</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6202"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Spinal Cord Stimulation Group</title>
          <description>Spinal Cord Stimulation (SCS) Treatment Group</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Small number of subjects; technical outcomes not necessarily predictive of therapeutic effectiveness.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Nitzan Mekel-Bobrov, Ph.D.</name_or_title>
      <organization>Boston Scientific</organization>
      <phone>(661) 949-4537</phone>
      <email>Nitzan.Mekel-Bobrov@bsci.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

